U.S. antitrust authorities and the German Federal Cartel Office cleared Varian Medical‘s (NYSE:VAR) $1.3B proposed buyout of Sirtex Medical (ASX:SRX), Varian reported today.
The companies first announced that they inked a deal for Varian to acquire all of Sirtex’s outstanding shares in January this year. The transaction is slated to close in late May.
Get the full story at our sister site, Drug Delivery Business News.
The post U.S., German antitrust authorities clear Varian’s $1.3B Sirtex buyout appeared first on MassDevice.
from MassDevice http://ift.tt/2HyeaCL
Cap comentari:
Publica un comentari a l'entrada